| Haleigh Ann Werner, MD | |
|
4525 3rd Ave Se, Suite 100, Lacey, WA 98503-1010 | |
| (360) 412-8960 | |
| (360) 412-8970 |
| Full Name | Haleigh Ann Werner |
|---|---|
| Gender | Female |
| Speciality | Radiation Oncology |
| Experience | 29 Years |
| Location | 4525 3rd Ave Se, Lacey, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508815440 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | MD00043314 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Centralia Hospital | Centralia, WA | Hospital |
| Providence St Peter Hospital | Olympia, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiantcare Physicians Pllc | 6608869581 | 5 |
News Archive
During the "first wave" of COVID-19 in the United States, Rajan Chakrabarty, the Harold D. Jolley Career Development Associate Professor at Washington University in St. Louis, learned that African Americans made up 47% of the population in St. Louis, but nearly three quarters of COVID-19 cases.
Today, EU policymakers, experts, patient representatives and other stakeholders gathered online to discuss the role of hormones in our everyday life, its interlinkage with prevalent non-communicable diseases and the policy measures required to address the many challenges in this rapidly growing area of human health.
MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it has been granted U.S. patent No. 7,824,588 from the United States Patent and Trademark Office (USPTO). The patent, issued on November 2, 2010, provides intellectual property protection for the Company's film products and methods of their preparation.
Researchers and physicians at Oregon Health & Science University, using artificial intelligence and automated monitoring, have designed a method to help people with type 1 diabetes better manage their glucose levels.
Scientists from the Jefferson Institute of Molecular Medicine of Thomas Jefferson University are now several steps closer to understanding the mechanism behind a novel systemic fibrotic disorder that affects some patients with renal insufficiency who receive imaging contrast agents for MRI. Two of their studies on the disorder appear together in the November issue of the Annals of Rheumatic Diseases.
› Verified 2 days ago
| Entity Name | Radiantcare Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851378160 PECOS PAC ID: 6608869581 Enrollment ID: O20040406001285 |
News Archive
During the "first wave" of COVID-19 in the United States, Rajan Chakrabarty, the Harold D. Jolley Career Development Associate Professor at Washington University in St. Louis, learned that African Americans made up 47% of the population in St. Louis, but nearly three quarters of COVID-19 cases.
Today, EU policymakers, experts, patient representatives and other stakeholders gathered online to discuss the role of hormones in our everyday life, its interlinkage with prevalent non-communicable diseases and the policy measures required to address the many challenges in this rapidly growing area of human health.
MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it has been granted U.S. patent No. 7,824,588 from the United States Patent and Trademark Office (USPTO). The patent, issued on November 2, 2010, provides intellectual property protection for the Company's film products and methods of their preparation.
Researchers and physicians at Oregon Health & Science University, using artificial intelligence and automated monitoring, have designed a method to help people with type 1 diabetes better manage their glucose levels.
Scientists from the Jefferson Institute of Molecular Medicine of Thomas Jefferson University are now several steps closer to understanding the mechanism behind a novel systemic fibrotic disorder that affects some patients with renal insufficiency who receive imaging contrast agents for MRI. Two of their studies on the disorder appear together in the November issue of the Annals of Rheumatic Diseases.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Haleigh Ann Werner, MD 4525 3rd Ave Se, Suite 100, Lacey, WA 98503-1010 Ph: (360) 412-8969 | Haleigh Ann Werner, MD 4525 3rd Ave Se, Suite 100, Lacey, WA 98503-1010 Ph: (360) 412-8960 |
News Archive
During the "first wave" of COVID-19 in the United States, Rajan Chakrabarty, the Harold D. Jolley Career Development Associate Professor at Washington University in St. Louis, learned that African Americans made up 47% of the population in St. Louis, but nearly three quarters of COVID-19 cases.
Today, EU policymakers, experts, patient representatives and other stakeholders gathered online to discuss the role of hormones in our everyday life, its interlinkage with prevalent non-communicable diseases and the policy measures required to address the many challenges in this rapidly growing area of human health.
MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it has been granted U.S. patent No. 7,824,588 from the United States Patent and Trademark Office (USPTO). The patent, issued on November 2, 2010, provides intellectual property protection for the Company's film products and methods of their preparation.
Researchers and physicians at Oregon Health & Science University, using artificial intelligence and automated monitoring, have designed a method to help people with type 1 diabetes better manage their glucose levels.
Scientists from the Jefferson Institute of Molecular Medicine of Thomas Jefferson University are now several steps closer to understanding the mechanism behind a novel systemic fibrotic disorder that affects some patients with renal insufficiency who receive imaging contrast agents for MRI. Two of their studies on the disorder appear together in the November issue of the Annals of Rheumatic Diseases.
› Verified 2 days ago
Justin William Suszko, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4525 3rd Ave Se Ste 100, Lacey, WA 98503 Phone: 360-412-8960 Fax: 360-412-8970 | |
Michael Connor, MD Radiology Medicare: Medicare Enrolled Practice Location: 4525 3rd Ave Se # 100, Lacey, WA 98503 Phone: 360-412-8960 | |
Joseph Robert Hartman, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 4525 3rd Ave Se, Suite 100, Lacey, WA 98503 Phone: 360-412-8960 Fax: 360-412-8970 | |
Gregory W Allen, M.D., PHD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4525 3rd Ave Se, Suite 100, Lacey, WA 98503 Phone: 360-412-8960 Fax: 360-412-8970 | |
James F Raymond, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4525 3rd Ave Se, Suite 100, Lacey, WA 98503 Phone: 360-412-8960 Fax: 360-412-8970 |